Eye Diseases

Showing 26 - 50 of 140

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Age-related Macular Degeneration, Macular Degeneration, Wet Macular Degeneration Trial in Germany, Switzerland (Brolucizumab)

Recruiting
  • Age-related Macular Degeneration
  • +5 more
  • Brolucizumab
  • Regensburg, Bavaria, Germany
  • +32 more
Jan 20, 2023

Age-Related Macular Degeneration, Diabetic Retinopathy, Central Serous Chorioretinopathy Trial in New York (OCT Imaging Using

Not yet recruiting
  • Age-Related Macular Degeneration
  • +5 more
  • OCT Imaging Using Device N
  • OCT Imaging Using Device C
  • New York, New York
    NYU Langone Health
Jan 6, 2023

Artificial Intelligent System for Eye Emergency Triage and

Recruiting
  • Emergencies
  • Eye Diseases
  • Artificial intelligent system for eye emergency triage and primary diagnosis
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity
Dec 25, 2022

Presbyopia, Refractive Error, Near Vision Trial in Glendale (Aceclidine + Brimonidine, Aceclidine, Brimonidine)

Recruiting
  • Presbyopia
  • +4 more
  • Aceclidine + Brimonidine
  • +2 more
  • Glendale, California
    Site #101
Jan 10, 2023

Eye Diseases Trial in Damieta (Transcutaneous levator recession)

Completed
  • Eye Diseases
  • Transcutaneous levator recession
  • Damieta, New Damietta, Egypt
    Ehab tharwat
Jan 1, 2023

Myopia, Refractive Errors, Eye Diseases Trial in Shanghai (RLRL)

Not yet recruiting
  • Myopia
  • +3 more
  • RLRL
  • Shanghai, Shanghai, China
    Shanghai Eye Disease Prevention and Treatment Center
Oct 24, 2022

Presbyopia, Refractive Errors, Eye Diseases Trial in United States (Aceclidine+Brimonidine combination ophthalmic solution,

Completed
  • Presbyopia
  • +2 more
  • Aceclidine+Brimonidine combination ophthalmic solution
  • +2 more
  • Glendale, California
  • +4 more
Oct 18, 2022

High Myopia, Refractive Errors, Eye Diseases Trial in Shanghai (RLRL)

Not yet recruiting
  • High Myopia
  • +2 more
  • RLRL
  • Shanghai, Shanghai, China
    Shanghai Eye Disease Prevention and Treatment Center
Oct 17, 2022

Multimodal Equipment for Teleophthalmology Assessment (META)

Not yet recruiting
  • Eye Diseases
  • META
  • Commercial devices
  • (no location specified)
Oct 3, 2022

Prophylactic PRP in Moderate NPDR

Completed
  • Eye Diseases
  • +2 more
  • PRP
  • Assiut, Egypt
    Assiut University
Sep 14, 2022

Eye Diseases Trial in Vienna (Laquinimod, Placebo)

Recruiting
  • Eye Diseases
  • Vienna, Austria
    Clinical trial center at Medical University Vienna
Aug 9, 2022

Presbyopia, Refractive Errors, Eye Diseases Trial in United States (Aceclidine+Brimonidine combination ophthalmic solution,

Recruiting
  • Presbyopia
  • +4 more
  • Aceclidine+Brimonidine combination ophthalmic solution
  • +2 more
  • Glendale, California
  • +3 more
Aug 3, 2022

Eye Diseases, Macular Degeneration, Wet, Sub-Macular Hemorrhage Trial in United Kingdom (Pars plana vitrectomy, Intravitreal 2

Recruiting
  • Eye Diseases
  • +2 more
  • Pars plana vitrectomy
  • +3 more
  • Chelmsford, Essex, United Kingdom
  • +13 more
Aug 2, 2022

Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Worldwide (Ultevursen, Sham-procedure)

Recruiting
  • Retinitis Pigmentosa
  • +7 more
  • San Diego, California
  • +14 more
Jul 29, 2022

Ocular Microbiome in Health and Disease

Recruiting
  • Microbial Colonization
  • +2 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jul 25, 2022

    Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham

    Active, not recruiting
    • Retinitis Pigmentosa
    • +6 more
    • Gene Therapy Product-vMCO-010
    • Sham Injection
    • Beverly Hills, California
    • +6 more
    Jul 13, 2022

    Trachomatous Trichiasis (TT), Eye Diseases, Eyelid Diseases Trial in Addis Ababa (Fluorometholone 0.1% Oph Susp, Artificial

    Recruiting
    • Trachomatous Trichiasis (TT)
    • +4 more
    • Fluorometholone 0.1% Oph Susp
    • Artificial Tears
    • Addis Ababa, Ethiopia
      Ministry of Science and Higher Education Ethiopia
    Jun 24, 2022

    Macular Degeneration, Retinal Degeneration, Retinal Diseases Trial in Boston (Pistachio Group)

    Recruiting
    • Macular Degeneration
    • +3 more
    • Pistachio Group
    • Boston, Massachusetts
      Clinical and Translational Research Center (CTRC) - Tufts
    Jun 9, 2022

    Natural History Study of CEP290-Related Retinal Degeneration

    Completed
    • Blindness
    • +7 more
      • Miami, Florida
      • +6 more
      May 18, 2022

      Age-Related Maculopathy, Age-Related Maculopathies, Eye Diseases Trial in United States (RN6G, Placebo)

      Completed
      • Age-Related Maculopathy
      • +4 more
      • RN6G
      • Placebo
      • Campbell, California
      • +23 more
      May 10, 2022

      Eye Diseases Trial in Guangzhou

      Recruiting
      • Eye Diseases
        • Guangzhou, Guangdong, China
          Zhongshan Ophthalmic Center
        May 4, 2022

        Eye Diseases, Ametropia Trial in Paris (SiVIEW software, Expert)

        Not yet recruiting
        • Eye Diseases
        • Ametropia
        • SiVIEW software
        • Expert
        • Paris, France
          Ophthalmological Foundation A. de Rothschild
        May 4, 2022

        Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Dallas, Madison, London (QR-421a, Sham-procedure)

        Active, not recruiting
        • Retinitis Pigmentosa
        • +7 more
        • Dallas, Texas
        • +2 more
        Apr 21, 2022

        Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Canada, France, United States (QR-421a, Sham-procedure (dose

        Completed
        • Retinitis Pigmentosa
        • +7 more
        • QR-421a
        • Sham-procedure (dose cohort 1&2 only)
        • Boston, Massachusetts
        • +6 more
        Apr 19, 2022

        Open Angle Glaucoma, Eye Diseases Trial in Guangzhou (RLRL therapy, Routine IOP-lowering medications)

        Not yet recruiting
        • Open Angle Glaucoma
        • Eye Diseases
        • RLRL therapy
        • Routine IOP-lowering medications
        • Guangzhou, Guangdong, China
          Zhongshan Ophthalmic Center, Sun Yat-sen University
        Mar 25, 2022